Page values for "Lactulose"
Appearance
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Lactulose |
| brand | String | Kristalose, Constulose, Generlac, Enulose |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Osmotic_laxatives|Osmotic laxative]] • [[:Category:Disaccharides|Non-absorbable disaccharide]] • [[:Category:Hepatic_encephalopathy_treatments|Hepatic encephalopathy treatment]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000F5C-QINU`"', '"`UNIQ--vote-00000F5D-QINU`"' |
| starting_dose | String | Constipation: 15-30 mL PO daily (titrate to 1-2 soft stools/day); hepatic encephalopathy: 20-30 g (30-45 mL) PO/PR every 1-2 hours acutely until soft stools, then BID-QID to target 2-3 soft stools/day |
| preparations | String | 10 g/15 mL solution (Constulose); 10 g, 20 g powder packets (Kristalose) |
| fda_max | String | Indication-specific; HE may require high-volume dosing |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • rectal (enema • especially in acute HE) |
| onset | String | Constipation: 24-48 hours; HE: ammonia reduction within hours of stool production |
| duration | String | Hours |
| halflife | String | Not meaningfully described — lactulose is not significantly absorbed |
| bioavailability | String | <3% systemic absorption (the basis of the safety and mechanism)'"`UNIQ--ref-00000F5E-QINU`"' |
| pregnancy | String | Generally considered safe (minimal systemic absorption).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |